课题基金 / 基金详情

Staphylococcus aureus biofilms: in vitro and in vivo studies

Staphylococcus aureus biofilms: in vitro and in vivo studies
金黄色葡萄球菌生物膜:体外和体内研究
批准号:
7423938
负责人:
Mark E Shirtliff
金额:
$36.42万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-01 至 2012-05-31

项目摘要

项目成果

Mark E Shirtliff的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):金黄色葡萄球菌是一种革兰氏阳性,普遍存在的细菌物种,自然界中主要的宿主是人类。越来越多地使用植入医疗器械,如髓内棒、螺钉、钢板和人工关节,为微生物引起感染提供了生理环境。虽然许多细菌种类可能引起留置医疗器械的微生物污染,但金黄色葡萄球菌引起大多数这些感染,产生高慢性、发病率和死亡率。金黄色葡萄球菌能够在留置医疗器械上引起持续感染的一个重要机制是通过定殖和合成一种“黏液”层,称为糖萼或生物膜。这一层阻止了抗菌剂和宿主吞噬细胞对感染的分解。一旦种植体被定植,慢性感染随之而来,标准的治疗选择是移除种植体。本研究旨在利用二维凝胶电泳技术鉴定金黄色葡萄球菌基因产物在生物膜中的表达上调。选择的上调蛋白将被评估,首先,它们在体内生物膜感染期间被宿主免疫系统识别的能力,其次,它们在兔子植入物相关感染模型中预防感染的保护功效。这里产生的数据可能有助于最终开发针对人类金黄色葡萄球菌生物膜感染的疫苗。此外,这一建议也将有助于更全面地了解金黄色葡萄球菌生物膜形成和成熟过程中涉及的细菌因素。这种理解将使人们能够创造新的材料、表面和/或消毒策略,以抵抗或消除葡萄球菌污染和生物膜的形成。此外,蛋白质组将与Pi实验室已经完成的转录组DMA微阵列研究进行比较,以确定在流动中生长的金黄色葡萄球菌生物膜的基因表达和蛋白质生产之间的全球相互关系,从而使葡萄球菌在一个新的水平上得到理解。最后,金黄色葡萄球菌生物膜形成的评价结果可作为其他密切相关的革兰氏阳性细菌(包括链球菌、李斯特菌、梭状芽孢杆菌和芽孢杆菌)生物膜形成的模型。
英文摘要
DESCRIPTION (provided by applicant): Staphylococcus aureus is a gram positive, ubiquitous bacterial species, with the predominant reservoir in nature being humans. The increased use of implanted medical devices such as intramedullary rods, screws, plates, and artificial joints has provided a physiological niche for microbes to cause infections. While a number of bacterial species may cause microbial fouling of indwelling medical devices, S. aureus causes a majority of these infections, producing high chronicity, morbidity, and mortality. One of the important mechanisms by which S. aureus is able to cause persistent infections on indwelling medical devices is through colonizing and synthesizing a "slime" layer, termed the glycocalyx or biofilm. This layer prevents infection resolution by antimicrobial agents and host phagocytic cells. Once an implant is colonized and chronic infection ensues, the standard treatment option is implant removal. This proposal seeks to identify S. aureus gene products with upregulated production in biofilms using two dimensional (2D) gel electrophoresis. Selected up-regulated proteins will then be evaluated, first, for their ability to be recognized by the host immune system during an in vivo biofilm infection, and second, for their protective efficacy in preventing infections in an implant-associated infection model in rabbits. The data generated here may contribute to the eventual development of a vaccine against S. aureus biofilms infections in humans. In addition, this proposal will also contribute to a more complete understanding of the bacterial factors involved in S. aureus biofilm formation and maturation. This understanding will enable one to create novel materials, surfaces, and/or disinfection strategies that resist or eliminate staphylococcal fouling and biofilm formation. Also, the proteome will be compared to transcriptome DMA microarray studies already completed in the Pi's laboratory in order to determine the global interrelation between gene expression and protein production for S. aureus biofilms grown under flow, thereby allowing staphylococci to be understood at a new level. Lastly, the results obtained in the evaluation of S. aureus biofilm formation may be used as a model for the biofilm formation by other closely related gram positive bacterial species, including Streptococcus spp., Listeria spp., Clostridium spp. and Bacillus spp.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Staphylococcus aureus biofilms: in vitro and in vivo studies
  • 批准号:
    8116811
  • 项目类别:
  • 资助金额:
    $31.95万
  • 财政年份:
    2010
  • 负责人:
    Mark E Shirtliff
  • 依托单位:
Staphylococcus aureus biofilms: in vitro and in vivo studies
  • 批准号:
    7618784
  • 项目类别:
  • 资助金额:
    $36.42万
  • 财政年份:
    2007
  • 负责人:
    Mark E Shirtliff
  • 依托单位:
Staphylococcus aureus biofilms: in vitro and in vivo studies
  • 批准号:
    7890454
  • 项目类别:
  • 资助金额:
    $36.06万
  • 财政年份:
    2007
  • 负责人:
    Mark E Shirtliff
  • 依托单位:
Staphylococcus aureus biofilms: in vitro and in vivo studies
  • 批准号:
    7320471
  • 项目类别:
  • 资助金额:
    $37.13万
  • 财政年份:
    2007
  • 负责人:
    Mark E Shirtliff
  • 依托单位:
海外基金